Analyses were performed using SAS (version 9.2; SAS Institute, Cary, NC). All P values are two-sided. Values of P < 0.05 were considered statistically significant. The last observed A1C value was carried forward for subjects who entered but did not complete the continuation phase. Comparison of within-treatment group A1C values at different time points was performed with a repeated ANCOVA model that included visit number, sex, and pooled investigational center as categorical variables and BMI, duration of diabetes, and week-52 A1C values as continuous variables. Sensor wear time was calculated as the average number of sensor glucose readings per day divided by the number of 5-minute intervals in a day (ie, 288). A general linear model with sex and pooled investigational center as categorical variables and BMI, duration of diabetes, week-52 A1C values, and sensor wear time as continuous variables was used to examine the relationship between sensor wear and A1C reduction. Wilcoxon's
test was used to evaluate sensor wear times between treatment groups. Subjects were assigned to adult (age 19-70) or pediatric (age 7-18) age groups at study entry; subjects who reached their 19th birthday while participating in the study were not reassigned to the adult age group. Rates of severe hypoglycemia and diabetic ketoacidosis were compared with Fisher's exact test. Areas under glucose concentration-time curves were compared via two-sample ttests (between-group comparisons) or paired t-tests (within-group comparisons). 
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